Laine I, et al. - Researchers undertook a comparative examination of the short-term effects of three monthly intravitreal bevacizumab (IVB) injections to single dexamethasone (DEX) implantation in treatment-naive patients with cystoid macular edema (CME) secondary to branch (BRVO) and central retinal vein occlusion (CRVO). A link was revealed between DEX with faster resolution of CME. However, it illustrated a greater probability for short-term intraocular pressure (IOP) elevation when compared to IVB. The treatments were found to be comparably effective, after the third month. Anatomical outcomes and adverse drug reactions of IVB vs DEX were recommended to be regarded as case specifically in patients having CME secondary to BRVO/CRVO.